"10.1371_journal.pone.0028626","plos one","2012-01-11T00:00:00Z","Mark A Little; Bahjat Al-Ani; Shuyu Ren; Hamad Al-Nuaimi; Maurilo Leite; Charles E Alpers; Caroline O Savage; Jeremy S Duffield","Centre for Nephrology, Royal Free Hospital, University College London, London, United Kingdom; Renal Institute of Birmingham, School of Infection, Immunology and Inflammation, University of Birmingham, Birmingham, United Kingdom; Division of Nephrology, Department of Medicine, Center for Lung Biology and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, United States of America; Division of Nephrology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Department of Pathology, University of Washington, Seattle, Washington, United States of America; GlaxoSmithKline UK Ltd, Uxbridge, United Kingdom","Conceived and designed the experiments: MAL COS JSD. Performed the experiments: BA-A SR HA-N ML MAL JSD. Analyzed the data: MAL COS CEA JSD. Wrote the manuscript: MAL COS JSD.","C.O.S. is employed by GSK. This study was partly funded by a GRIP award from Genzyme. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","01","Mark A Little","MAL",8,TRUE,3,6,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
